Found: 14
Select item for more details and to access through your institution.
Tumor Necrosis Factor Inhibitors Provide Longterm Clinical Benefits in Pediatric and Young Adult Patients with Blau Syndrome.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Frequent methylprednisone pulse therapy is a risk factor for steroid cataracts in children.
- Published in:
- Pediatrics International, 2008, v. 50, n. 4, p. 541, doi. 10.1111/j.1442-200X.2008.02629.x
- By:
- Publication type:
- Article
Kawasaki syndrome and 21-hydroxylase deficiency.
- Published in:
- Pediatrics International, 2008, v. 50, n. 1, p. 119, doi. 10.1111/j.1442-200X.2007.02520.x
- By:
- Publication type:
- Article
Utility of the EULAR Sjögren syndrome disease activity index in Japanese children: a retrospective multicenter cohort study.
- Published in:
- Pediatric Rheumatology, 2020, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12969-020-00458-1
- By:
- Publication type:
- Article
A case of cryopyrin-associated periodic fever syndrome during canakinumab administration complicated by inflammatory bowel disease.
- Published in:
- Clinical Rheumatology, 2021, v. 40, n. 1, p. 393, doi. 10.1007/s10067-020-05267-1
- By:
- Publication type:
- Article
S100A12 and vascular endothelial growth factor can differentiate Blau syndrome and familial Mediterranean fever from systemic juvenile idiopathic arthritis.
- Published in:
- Clinical Rheumatology, 2019, v. 38, n. 3, p. 835, doi. 10.1007/s10067-018-4359-9
- By:
- Publication type:
- Article
Sewing needles in the abdominal cavity assumed to have been ingested and to have penetrated the GI tract 40 years ago: A case report.
- Published in:
- Asian Journal of Endoscopic Surgery, 2017, v. 10, n. 4, p. 446, doi. 10.1111/ases.12375
- By:
- Publication type:
- Article
Clinical practice guidance for Sjögren's syndrome in pediatric patients (2018) -summarized and updated.
- Published in:
- Modern Rheumatology, 2021, v. 31, n. 2, p. 283, doi. 10.1080/14397595.2020.1816319
- By:
- Publication type:
- Article
Prediction of long-term remission of oligo/polyarticular juvenile idiopathic arthritis with S100A12 and vascular endothelial growth factor.
- Published in:
- Modern Rheumatology, 2016, v. 26, n. 4, p. 551, doi. 10.3109/14397595.2015.1109784
- By:
- Publication type:
- Article
The safety and effectiveness of HBV vaccination in patients with juvenile idiopathic arthritis controlled by treatment.
- Published in:
- Modern Rheumatology, 2016, v. 26, n. 3, p. 368, doi. 10.3109/14397595.2015.1085608
- By:
- Publication type:
- Article
Disease activity score in 28 joints at 3 months after the initiation of biologic agent can be a predictive target for switching to the second biologic agent in patients with polyarticular juvenile idiopathic arthritis.
- Published in:
- Modern Rheumatology, 2016, v. 26, n. 3, p. 358, doi. 10.3109/14397595.2015.1083147
- By:
- Publication type:
- Article
Efficacy and safety of orally administered pilocarpine hydrochloride for patients with juvenile-onset Sjögren's syndrome.
- Published in:
- Modern Rheumatology, 2010, v. 20, n. 5, p. 486, doi. 10.3109/s10165-010-0313-7
- By:
- Publication type:
- Article
A case of planned pregnancy with an interruption in infliximab administration in a 27-year-old female patient with rheumatoid-factor-positive polyarthritis juvenile idiopathic arthritis which improved after restarting infliximab and methotrexate.
- Published in:
- Modern Rheumatology, 2008, v. 18, n. 2, p. 189, doi. 10.3109/s10165-008-0024-5
- By:
- Publication type:
- Article
Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis.
- Published in:
- Modern Rheumatology, 2007, v. 17, n. 6, p. 526, doi. 10.3109/s10165-007-0634-3
- By:
- Publication type:
- Article